HC Wainwright & Co. Maintains Buy on Alpha Tau Medical, Raises Price Target to $18
Benzinga Newsdesk 11 hours ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
HC Wainwright & Co. analyst Yi Chen maintains Alpha Tau Medical (NASDAQ:DRTS) with a Buy and raises the price target from $16 to $18.
HC Wainwright & Co. analyst Yi Chen maintains Alpha Tau Medical (NASDAQ:DRTS) with a Buy and raises the price target from $16 to $18.
More on DRTS
Earnings Benzinga
Alpha Tau Medical Q3 EPS $(0.33) Misses $(0.15) EstimateAlpha Tau Medical (NASDAQ:DRTS) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of $(0.15) by 120 percent. This is a 135.71 percent decrease over losses of…
